DK79591A - Behandling af genitale vorter med en kombination af flydende nitrogen og rekombinant dna human alfa-interferon - Google Patents

Behandling af genitale vorter med en kombination af flydende nitrogen og rekombinant dna human alfa-interferon Download PDF

Info

Publication number
DK79591A
DK79591A DK079591A DK79591A DK79591A DK 79591 A DK79591 A DK 79591A DK 079591 A DK079591 A DK 079591A DK 79591 A DK79591 A DK 79591A DK 79591 A DK79591 A DK 79591A
Authority
DK
Denmark
Prior art keywords
genital
warnings
interferon
treatment
combination
Prior art date
Application number
DK079591A
Other languages
Danish (da)
English (en)
Other versions
DK79591D0 (da
Inventor
Kenneth A Smiles
Edwin A Peets
Daniel J Tanner
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DK79591D0 publication Critical patent/DK79591D0/da
Publication of DK79591A publication Critical patent/DK79591A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK079591A 1988-11-01 1991-04-30 Behandling af genitale vorter med en kombination af flydende nitrogen og rekombinant dna human alfa-interferon DK79591A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/265,612 US4959210A (en) 1988-11-01 1988-11-01 Treatment of genital warts with a combination of liquid nitrogen and recombinant DNA human alpha interferon
PCT/US1989/004766 WO1990004977A2 (fr) 1988-11-01 1989-10-30 Traitement de condylomes genitaux a l'aide d'une combinaison d'azote liquide et d'interferon alpha humain d'adn de recombinaison

Publications (2)

Publication Number Publication Date
DK79591D0 DK79591D0 (da) 1991-04-30
DK79591A true DK79591A (da) 1991-06-14

Family

ID=23011173

Family Applications (1)

Application Number Title Priority Date Filing Date
DK079591A DK79591A (da) 1988-11-01 1991-04-30 Behandling af genitale vorter med en kombination af flydende nitrogen og rekombinant dna human alfa-interferon

Country Status (12)

Country Link
US (1) US4959210A (fr)
EP (2) EP0445145A1 (fr)
JP (1) JPH03503766A (fr)
KR (1) KR900701309A (fr)
AU (1) AU636312B2 (fr)
CA (1) CA2001884A1 (fr)
DK (1) DK79591A (fr)
IL (1) IL92161A0 (fr)
MY (1) MY106603A (fr)
PH (1) PH26680A (fr)
WO (1) WO1990004977A2 (fr)
ZA (1) ZA898234B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028422A (en) * 1986-05-27 1991-07-02 Schering Corporation Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
US5165921A (en) * 1989-01-23 1992-11-24 National Geno Sciences, Inc. Method for treating condyloma acuminatum with interferon
US6001826A (en) * 1989-12-21 1999-12-14 Anormed, Inc. Chemical compounds
PT99837A (pt) * 1990-12-21 1992-12-31 Schering Corp Processo para a preparacao de composicoes farmaceuticas contendo interferao alfa e metodo para administracao de interferao alfa por inalacao oral para tratar asma e doencas pulmonares proliferativas nao malignas
US6309662B1 (en) 1999-09-23 2001-10-30 Janet Buchanan Use of anti-inflammatory drugs for treatment of dermatological conditions
US7436227B2 (en) * 2003-05-02 2008-10-14 Silicon Laboratories Inc. Dual loop architecture useful for a programmable clock source and clock multiplier applications
WO2005074546A2 (fr) 2004-02-02 2005-08-18 Ambrx, Inc. Polypeptides d'hormone de croissance humaine modifies et utilisations
US20110218241A1 (en) * 2010-03-06 2011-09-08 Cacao Bio-Technologies, Llc Antiviral epicatechins, epicatechin oligomers, or thiolated epicatechins from theobroma cacao for treatment of genital warts
EP3600379B1 (fr) 2017-03-31 2022-12-21 Accanis Biotech F&E GmbH & Co KG Prévention et traitement de cancer de la peau non mélanique (nmsc)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4503035B1 (en) * 1978-11-24 1996-03-19 Hoffmann La Roche Protein purification process and product
US4286690A (en) * 1979-03-05 1981-09-01 Commercial Management Corporation Escape device
JPS59175416A (ja) * 1983-03-25 1984-10-04 Sunstar Inc 皮膚および粘膜の角化異常治療用外用剤
CA1321347C (fr) * 1986-11-10 1993-08-17 David C. Munch Composition d'interferon humain leucocytaire et traitement de la peau

Also Published As

Publication number Publication date
CA2001884A1 (fr) 1990-05-01
DK79591D0 (da) 1991-04-30
WO1990004977A2 (fr) 1990-05-17
WO1990004977A3 (fr) 1990-06-28
KR900701309A (ko) 1990-12-01
IL92161A0 (en) 1990-07-12
MY106603A (en) 1995-06-30
EP0369632A1 (fr) 1990-05-23
ZA898234B (en) 1990-07-25
AU4524689A (en) 1990-05-28
AU636312B2 (en) 1993-04-29
EP0445145A1 (fr) 1991-09-11
JPH03503766A (ja) 1991-08-22
US4959210A (en) 1990-09-25
PH26680A (en) 1992-09-15

Similar Documents

Publication Publication Date Title
DK0445255T3 (da) Behandling af tilstande og sygdom
DK316988A (da) Transdermalt farmaceutisk praeparat og dets anvendelse
DK476089A (da) Terapeutisk aktive forbindelser og deres fremstilling
DK139191D0 (da) Anvendelse af et n-acylcystein og middel indeholdende et n-acylcystein
IL90874A0 (en) Adjustable wrist and hand splint
DK609887D0 (da) Indretning til selvadministrering af fysiologisk virksomme substanser og med forebyggelse mod overdosering
DK79591D0 (da) Behandling af genitale vorter med en kombination af flydende nitrogen og rekombinant dna human alfa-interferon
DK431987A (da) Fremgangsmaade og middel til heling af knoglebeskadigelse
DK249688D0 (da) Laegemiddelkombination til forebyggelse og behandling af malaria
NO933284D0 (no) Forbindelser med flytende krystall-egenskaper og belegninsbindemidle
DK139393D0 (da) Laegetermometer med digitalt og talende display
DK103390D0 (da) Fremgangsmaade og anlaeg til optraekning af et neddykket legeme
DK464986A (da) Peptid-antagonister af neurokinin b og ophthalmiske oploesninger med indhold deraf
DK365286A (da) 7-oxabicycloheptan-substituerede disyre-diamid-prosta-glandin-analoge og deres anvendelse
DK467087D0 (da) Lymphocytaktiverende polypeptider og deres anvendelse
DK634089A (da) Polyhydroxybenzyloxypropanolaminer og deres anvendelse
DK131189A (da) Fremgangsmaade og middel til ophthalmisk anaestesi
ZA895010B (en) Treatment of genital warts with a combination of podophyllin and recombinant dna human alpha interferion
DK394488D0 (da) 5-pyrimidincarboxamider og behandling af leukaemi dermed
DK394388D0 (da) 5-pyrimidincarboxamider og behandling af leukaemi dermed
FR2650946B1 (fr) Attelle pour poignet et pouce
DK423789D0 (da) Ekspression og anvendelse af et humant plasmaglycoprotein
DK29687D0 (da) Antihypoxisk medikament med cerebro og hepatobeskyttende virkning og anvendelse af samme
DK670588A (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
DK75691A (da) Ny farmaceutisk anvendelse af fusidin og derivater deraf